A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

North Dakota and South Dakota also failed in their efforts to legalize cannabis for recreational use, while a medical measure ...

Speaking of medical product, the one bright spot in the 2024 election is that, of the two votes that passed in Nebraska, one ...

Shares of cannabis companies fell Wednesday after a ballot measure that would have legalized recreational marijuana in ...

Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...

Amendment 3 – which would have legalized the recreational use of marijuana in the state’s constitution – failed to receive ...

On July 15, 2024, Tilray Medical was the first to receive a new cannabis cultivation license issued under MedCanG. This license allows Aphria RX to cultivate and manufacture a broad range of ...

It's the latest blow for weed companies that have been hoping for good news as federal rescheduling has lagged.

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before ...

A ballot measure to legalize recreational pot failed to reach the required 60 percent threshold for passage, and publicly listed companies' shares dropped after a major market was closed to them.

Cannabis stocks tanked on Wednesday, led by Florida’s biggest medical-cannabis operator Trulieve, which had backed a campaign for adult recreational legalization in Florida that failed to garner ...